Persistence of Cholinesterase Inhibitor Treatment in Dementia: Insights from a Naturalistic Study

Publisher： Karger

E-ISSN： 1664-5464|3|1|48-59

ISSN： 1664-5464

Source： Dementia and Geriatric Cognitive Disorders Extra, Vol.3, Iss.1, 2013-03, pp. : 48-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Dementia in Parkinsonian Syndromes with Cholinesterase Inhibitors

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 6, 2007-03 ,pp. : 351-367

Karger

Access to resources Recommend Favorite

Ginkgo biloba Compared with Cholinesterase Inhibitors in the Treatment of Dementia: A Review Based on Meta-Analyses by the Cochrane Collaboration

By  

Dementia and Geriatric Cognitive Disorders, Vol. 18, Iss. 2, 2004-08 ,pp. : 217-226

Karger

Access to resources Recommend Favorite

A Controlled Naturalistic Study on a Weekly Music Therapy and Activity Program on Disruptive and Depressive Behaviors in Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 30, Iss. 6, 2011-01 ,pp. : 540-546

Karger

Access to resources Recommend Favorite

Economic Analysis of Galantamine, a Cholinesterase Inhibitor, in the Treatment of Patients with Mild to Moderate Alzheimer’s Disease in The Netherlands

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 2, 2002-07 ,pp. : 84-89

Karger

Access to resources Recommend Favorite

Long-Term Response to Cholinesterase Inhibitor Treatment Is Related to Functional MRI Response in Alzheimer's Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 40, Iss. 5-6, 2015-0 ,pp. : 243-255

Karger

Access to resources Recommend Favorite